BRAF is a serine-threonine protein kinase mutated in almost the 50%–60% of melanomas [2] mostly harbouring the mutation V600E that increases the protein kinase activity, the consequent activation of the BRAF/MAPK/ERK signalling pathways and therefore the tumour cell growth and proliferation [39]. The gene discussed is BRAF; the disease is melanoma.